Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients

Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson’s disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patie...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical neuroscience Vol. 21; no. 1; pp. 63 - 66
Main Authors: Phu, Amy L., Xu, Zheyu, Brakoulias, Vlasios, Mahant, Neil, Fung, Victor S.C., Moore, Gregory De, Martin, Andrew, Starcevic, Vladan, Krause, Martin
Format: Journal Article
Language:English
Published: Scotland Elsevier Ltd 01.01.2014
Subjects:
ISSN:0967-5868, 1532-2653, 1532-2653
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson’s disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patients with PD were included in the trial. The Unified Parkinson’s Disease Rating Scale (UPDRS), Mini Mental State Examination and the Parkinson’s Disease Questionnaire-39 were used to measure disease severity, cognition and disease-specific QoL. The diagnosis of ICRD was based on face-to-face structured clinical interviews by three psychiatrists with experience in ICRD using the Expanded Structured Clinical Interview for the Diagnostic and Statistical Manual IV for Obsessive-Compulsive Disorder Related/Spectrum Disorders. ICRD were present in 15% of our patient population, and had a negative impact on QoL and Activity of Daily Living (ADL) scores. After adjusting for the presence of major depressive disorders and PD duration, the effect on emotional wellbeing remained statistically significant (p<0.004). Disease duration also correlated with worse QoL and ADL scores. Major depression disorders reduced QoL but not ADL. Patients with ICRD tended to suffer more from depression than those without ICRD. There were no statistically significant differences in age, sex, major depressive disorders, PD duration, total levodopa equivalent daily dose, use of dopamine agonists, or UPDRS motor score between patients with and without ICDR.
AbstractList Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson's disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patients with PD were included in the trial. The Unified Parkinson's Disease Rating Scale (UPDRS), Mini Mental State Examination and the Parkinson's Disease Questionnaire-39 were used to measure disease severity, cognition and disease-specific QoL. The diagnosis of ICRD was based on face-to-face structured clinical interviews by three psychiatrists with experience in ICRD using the Expanded Structured Clinical Interview for the Diagnostic and Statistical Manual IV for Obsessive-Compulsive Disorder Related/Spectrum Disorders. ICRD were present in 15% of our patient population, and had a negative impact on QoL and Activity of Daily Living (ADL) scores. After adjusting for the presence of major depressive disorders and PD duration, the effect on emotional wellbeing remained statistically significant (p<0.004). Disease duration also correlated with worse QoL and ADL scores. Major depression disorders reduced QoL but not ADL. Patients with ICRD tended to suffer more from depression than those without ICRD. There were no statistically significant differences in age, sex, major depressive disorders, PD duration, total levodopa equivalent daily dose, use of dopamine agonists, or UPDRS motor score between patients with and without ICDR.Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson's disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patients with PD were included in the trial. The Unified Parkinson's Disease Rating Scale (UPDRS), Mini Mental State Examination and the Parkinson's Disease Questionnaire-39 were used to measure disease severity, cognition and disease-specific QoL. The diagnosis of ICRD was based on face-to-face structured clinical interviews by three psychiatrists with experience in ICRD using the Expanded Structured Clinical Interview for the Diagnostic and Statistical Manual IV for Obsessive-Compulsive Disorder Related/Spectrum Disorders. ICRD were present in 15% of our patient population, and had a negative impact on QoL and Activity of Daily Living (ADL) scores. After adjusting for the presence of major depressive disorders and PD duration, the effect on emotional wellbeing remained statistically significant (p<0.004). Disease duration also correlated with worse QoL and ADL scores. Major depression disorders reduced QoL but not ADL. Patients with ICRD tended to suffer more from depression than those without ICRD. There were no statistically significant differences in age, sex, major depressive disorders, PD duration, total levodopa equivalent daily dose, use of dopamine agonists, or UPDRS motor score between patients with and without ICDR.
Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson's disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patients with PD were included in the trial. The Unified Parkinson's Disease Rating Scale (UPDRS), Mini Mental State Examination and the Parkinson's Disease Questionnaire-39 were used to measure disease severity, cognition and disease-specific QoL. The diagnosis of ICRD was based on face-to-face structured clinical interviews by three psychiatrists with experience in ICRD using the Expanded Structured Clinical Interview for the Diagnostic and Statistical Manual IV for Obsessive-Compulsive Disorder Related/Spectrum Disorders. ICRD were present in 15% of our patient population, and had a negative impact on QoL and Activity of Daily Living (ADL) scores. After adjusting for the presence of major depressive disorders and PD duration, the effect on emotional wellbeing remained statistically significant (p < 0.004). Disease duration also correlated with worse QoL and ADL scores. Major depression disorders reduced QoL but not ADL. Patients with ICRD tended to suffer more from depression than those without ICRD. There were no statistically significant differences in age, sex, major depressive disorders, PD duration, total levodopa equivalent daily dose, use of dopamine agonists, or UPDRS motor score between patients with and without ICDR.
Abstract Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson’s disease (PD). The present study aimed to investigate the effects of ICRD on quality of life (QoL) and disability in PD. From two movement disorder clinics in Sydney, Australia, 100 consecutive patients with PD were included in the trial. The Unified Parkinson’s Disease Rating Scale (UPDRS), Mini Mental State Examination and the Parkinson’s Disease Questionnaire-39 were used to measure disease severity, cognition and disease-specific QoL. The diagnosis of ICRD was based on face-to-face structured clinical interviews by three psychiatrists with experience in ICRD using the Expanded Structured Clinical Interview for the Diagnostic and Statistical Manual IV for Obsessive-Compulsive Disorder Related/Spectrum Disorders. ICRD were present in 15% of our patient population, and had a negative impact on QoL and Activity of Daily Living (ADL) scores. After adjusting for the presence of major depressive disorders and PD duration, the effect on emotional wellbeing remained statistically significant ( p < 0.004). Disease duration also correlated with worse QoL and ADL scores. Major depression disorders reduced QoL but not ADL. Patients with ICRD tended to suffer more from depression than those without ICRD. There were no statistically significant differences in age, sex, major depressive disorders, PD duration, total levodopa equivalent daily dose, use of dopamine agonists, or UPDRS motor score between patients with and without ICDR.
Author Xu, Zheyu
Fung, Victor S.C.
Phu, Amy L.
Starcevic, Vladan
Brakoulias, Vlasios
Mahant, Neil
Moore, Gregory De
Martin, Andrew
Krause, Martin
Author_xml – sequence: 1
  givenname: Amy L.
  surname: Phu
  fullname: Phu, Amy L.
  organization: University of Sydney, Nepean Clinical School, NSW, Australia
– sequence: 2
  givenname: Zheyu
  surname: Xu
  fullname: Xu, Zheyu
  organization: Movement Disorder Unit, Westmead Hospital, Westmead, NSW, Australia
– sequence: 3
  givenname: Vlasios
  surname: Brakoulias
  fullname: Brakoulias, Vlasios
  organization: University of Sydney, Nepean Clinical School, NSW, Australia
– sequence: 4
  givenname: Neil
  surname: Mahant
  fullname: Mahant, Neil
  organization: Movement Disorder Unit, Westmead Hospital, Westmead, NSW, Australia
– sequence: 5
  givenname: Victor S.C.
  surname: Fung
  fullname: Fung, Victor S.C.
  organization: Movement Disorder Unit, Westmead Hospital, Westmead, NSW, Australia
– sequence: 6
  givenname: Gregory De
  surname: Moore
  fullname: Moore, Gregory De
  organization: Movement Disorder Unit, Westmead Hospital, Westmead, NSW, Australia
– sequence: 7
  givenname: Andrew
  surname: Martin
  fullname: Martin, Andrew
  organization: NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
– sequence: 8
  givenname: Vladan
  surname: Starcevic
  fullname: Starcevic, Vladan
  organization: University of Sydney, Nepean Clinical School, NSW, Australia
– sequence: 9
  givenname: Martin
  surname: Krause
  fullname: Krause, Martin
  email: martin.krause@sydney.edu.au
  organization: University of Sydney, Nepean Clinical School, NSW, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24035421$$D View this record in MEDLINE/PubMed
BookMark eNqFks9qFTEYxYNU7G31BVxIlm5mzL_JzIgIpdQ_UFBQwV3IJF8k07nJbTIj3J2v4ev5JGa81UXBdpUEzu8kOec7QUchBkDoKSU1JVS-GOsxmlAzQnlNWE04e4A2tOGsYrLhR2hDetlWTSe7Y3SS80gI6QUnj9AxE4Q3gtEN-nbhHJgZR4f9drdMGbCJYU5xwtbnmCykjGNYD3rwk5_3WAeLrxf9Z1-wyTvAPuCPOl35kGP49eNnXvWgi9lOzx7CnB-jh04X9yc36yn68ubi8_m76vLD2_fnZ5eVEX0zV6yzPaO8lQxEM1ABtnVsIK22xBEmjOu4NUAHy2zbss6Vv4OEgUDb99Drhp-i5wffXYrXC-RZbX02ME06QFyyog2VrRBUyvulQpa3dFTSIn12I12GLVi1S36r0179zbEI2EFgUsw5gfsnoUStZalRrWWptSxFmCplFai7BRk_l7zW_LWf7kZfHVAoWX73kFQ2JWcD1qdSp7LR342_voWbyQdv9HQFe8hjXFIoLSmqcgHUp3WQ1jminJQW-q_F4OX_De67_TczRtlA
CitedBy_id crossref_primary_10_1016_j_biopsych_2024_06_027
crossref_primary_10_1016_j_jns_2017_01_026
crossref_primary_10_1038_s41598_020_69760_y
crossref_primary_10_1016_j_neurol_2024_07_001
crossref_primary_10_1177_0891988720915525
crossref_primary_10_1136_jnnp_2015_311827
crossref_primary_10_1111_ene_13078
crossref_primary_10_1371_journal_pone_0217700
crossref_primary_10_1007_s10072_025_08448_5
crossref_primary_10_1007_s40264_024_01471_z
crossref_primary_10_1212_CPJ_0000000000200205
crossref_primary_10_1155_2016_7951840
crossref_primary_10_1007_s00415_018_8803_1
crossref_primary_10_1080_23279095_2025_2499856
crossref_primary_10_1007_s00415_021_10724_1
crossref_primary_10_1586_14737175_2016_1158103
crossref_primary_10_3390_jcm13226708
crossref_primary_10_1002_mds_26016
crossref_primary_10_1186_s42466_019_0013_5
crossref_primary_10_1093_ageing_afy158
crossref_primary_10_1016_j_jns_2024_123205
crossref_primary_10_1177_0891988715606233
crossref_primary_10_1111_ene_14177
crossref_primary_10_1007_s40263_024_01087_y
crossref_primary_10_1007_s11910_018_0875_x
crossref_primary_10_1016_j_parkreldis_2019_02_042
crossref_primary_10_1136_jnnp_2024_334116
crossref_primary_10_1186_s12955_015_0281_x
crossref_primary_10_1007_s11136_022_03321_w
crossref_primary_10_1159_000478849
crossref_primary_10_1016_j_jpsychores_2018_05_007
crossref_primary_10_1111_ene_12646
crossref_primary_10_1212_WNL_0000000000010965
crossref_primary_10_1007_s00415_019_09588_3
crossref_primary_10_1016_j_neurol_2018_07_009
crossref_primary_10_1016_j_jns_2016_12_060
crossref_primary_10_3233_JPD_150747
crossref_primary_10_3389_fnagi_2023_1257618
crossref_primary_10_1212_WNL_0000000000000729
crossref_primary_10_1155_2024_8770997
crossref_primary_10_1002_mds_27885
crossref_primary_10_3389_fpsyt_2016_00091
crossref_primary_10_1016_j_jns_2015_04_013
crossref_primary_10_1080_08870446_2016_1218879
crossref_primary_10_1007_s00221_020_05768_0
crossref_primary_10_1016_S1474_4422_18_30127_3
crossref_primary_10_3390_medicina59111942
crossref_primary_10_1016_j_jocn_2019_07_069
crossref_primary_10_1016_j_jad_2020_11_075
crossref_primary_10_1016_j_neubiorev_2016_11_021
crossref_primary_10_1016_j_jns_2016_07_003
crossref_primary_10_1136_jnnp_2015_312848
crossref_primary_10_1159_000528900
crossref_primary_10_1016_j_parkreldis_2020_07_007
crossref_primary_10_3389_fneur_2018_00330
crossref_primary_10_1097_WNF_0000000000000202
crossref_primary_10_1016_j_psychres_2018_05_006
crossref_primary_10_1016_j_neurobiolaging_2018_11_021
crossref_primary_10_3389_fneur_2019_00086
Cites_doi 10.1053/comp.2001.24586
10.1002/mds.21071
10.1097/NRL.0b013e31823d7abb
10.3410/M1-29
10.1002/mds.23501
10.1002/ana.22356
10.1016/j.jns.2006.05.030
10.1097/NRL.0b013e3181e8868b
10.1016/S1353-8020(09)70794-1
10.1002/mds.10011
10.1002/gps.2704
10.1002/mds.10010
10.1111/j.1532-5415.2005.53221.x
10.1002/mds.20213
10.1111/j.1532-5415.2004.52219.x
10.1002/mds.10459
10.1016/0022-3956(75)90026-6
10.1056/NEJMoa060281
10.1016/j.parkreldis.2011.09.007
10.1002/mds.22571
10.1111/j.1360-0443.2010.03218.x
10.1001/archneurol.2010.65
10.1093/ageing/26.5.353
10.1212/01.wnl.0000184487.72289.f0
10.1016/S1353-8020(09)70847-8
10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#
10.1016/j.parkreldis.2011.10.005
ContentType Journal Article
Copyright 2013
Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2013
– notice: Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
DOI 10.1016/j.jocn.2013.02.032
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE - Academic
Neurosciences Abstracts



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2653
EndPage 66
ExternalDocumentID 24035421
10_1016_j_jocn_2013_02_032
S096758681300249X
1_s2_0_S096758681300249X
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABJNI
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSN
SSZ
T5K
UHS
WUQ
Z5R
~G-
~HD
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AJBFU
LCYCR
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
ID FETCH-LOGICAL-c495t-28d9213762e45b14ed7f2b07ad0f024cf83dce1bd2d7728f201e6eb0e799e9a53
ISICitedReferencesCount 84
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000330149900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0967-5868
1532-2653
IngestDate Sun Sep 28 11:22:27 EDT 2025
Sun Nov 09 11:32:53 EST 2025
Mon Jul 21 05:56:34 EDT 2025
Sat Nov 29 02:57:21 EST 2025
Tue Nov 18 22:30:51 EST 2025
Fri Feb 23 02:27:09 EST 2024
Sun Feb 23 10:19:23 EST 2025
Tue Oct 14 19:34:20 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Activity of daily living
Impulse control and related disorders
Idiopathic Parkinson’s disease
Quality of life
Language English
License Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c495t-28d9213762e45b14ed7f2b07ad0f024cf83dce1bd2d7728f201e6eb0e799e9a53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 24035421
PQID 1469218161
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1516744166
proquest_miscellaneous_1469218161
pubmed_primary_24035421
crossref_primary_10_1016_j_jocn_2013_02_032
crossref_citationtrail_10_1016_j_jocn_2013_02_032
elsevier_sciencedirect_doi_10_1016_j_jocn_2013_02_032
elsevier_clinicalkeyesjournals_1_s2_0_S096758681300249X
elsevier_clinicalkey_doi_10_1016_j_jocn_2013_02_032
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Scotland
PublicationPlace_xml – name: Scotland
PublicationTitle Journal of clinical neuroscience
PublicationTitleAlternate J Clin Neurosci
PublicationYear 2014
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Schrag (b0115) 2006; 248
du Toit, van Kradenburg, Niehaus (b0055) 2001; 42
Stacy (b0030) 2009; 1
Weintraub (b0005) 2009; 15
Forjaz, Martinez-Martin (b0120) 2006; 21
Bernal-Pacheco, Limotai, Go (b0140) 2012; 18
Weintraub, Moberg, Duda (b0015) 2004; 52
Antonini, Siri, Santangelo (b0100) 2011; 26
Joutsa, Martikainen, Vahlberg (b0130) 2012; 18
Kuopio, Marttila, Helenius (b0045) 2000; 15
Siderowf, McDermott, Kieburtz (b0065) 2002; 17
Deuschl, Schade-Brittinger, Krack (b0080) 2006; 355
(b0040) 2002; 17
Weintraub, Koester, Potenza (b0025) 2010; 67
Leroi, Harbishettar, Andrews (b0135) 2012; 27
Jenkinson, Fitzpatrick, Peto (b0085) 1997; 26
Ambermoon, Carter, Hall (b0010) 2011; 106
Nasreddine, Phillips, Bedirian (b0070) 2005; 53
Weiss, Hirsch, Williams (b0095) 2010; 16
Evans, Lawrence, Potts (b0020) 2005; 65
Sheehan, Lecrubier, Sheehan (b0060) 1998; 59
Weintraub, Hoops, Shea (b0090) 2009; 24
Goetz, Poewe, Rascol (b0125) 2004; 19
Ceravolo, Frosini, Rossi (b0035) 2009; 15
Folstein, Folstein, McHugh (b0075) 1975; 12
Leroi, Andrews, McDonald (b0110) 2012; 18
Voon, Sohr, Lang (b0105) 2011; 69
Litvan, Bhatia, Burn (b0050) 2003; 18
Folstein (10.1016/j.jocn.2013.02.032_b0075) 1975; 12
Goetz (10.1016/j.jocn.2013.02.032_b0125) 2004; 19
Leroi (10.1016/j.jocn.2013.02.032_b0110) 2012; 18
Weintraub (10.1016/j.jocn.2013.02.032_b0015) 2004; 52
Stacy (10.1016/j.jocn.2013.02.032_b0030) 2009; 1
Weintraub (10.1016/j.jocn.2013.02.032_b0090) 2009; 24
Evans (10.1016/j.jocn.2013.02.032_b0020) 2005; 65
Joutsa (10.1016/j.jocn.2013.02.032_b0130) 2012; 18
du Toit (10.1016/j.jocn.2013.02.032_b0055) 2001; 42
Antonini (10.1016/j.jocn.2013.02.032_b0100) 2011; 26
Leroi (10.1016/j.jocn.2013.02.032_b0135) 2012; 27
Sheehan (10.1016/j.jocn.2013.02.032_b0060) 1998; 59
Forjaz (10.1016/j.jocn.2013.02.032_b0120) 2006; 21
Jenkinson (10.1016/j.jocn.2013.02.032_b0085) 1997; 26
Bernal-Pacheco (10.1016/j.jocn.2013.02.032_b0140) 2012; 18
Weiss (10.1016/j.jocn.2013.02.032_b0095) 2010; 16
Schrag (10.1016/j.jocn.2013.02.032_b0115) 2006; 248
Litvan (10.1016/j.jocn.2013.02.032_b0050) 2003; 18
Nasreddine (10.1016/j.jocn.2013.02.032_b0070) 2005; 53
Weintraub (10.1016/j.jocn.2013.02.032_b0005) 2009; 15
Weintraub (10.1016/j.jocn.2013.02.032_b0025) 2010; 67
(10.1016/j.jocn.2013.02.032_b0040) 2002; 17
Ceravolo (10.1016/j.jocn.2013.02.032_b0035) 2009; 15
Kuopio (10.1016/j.jocn.2013.02.032_b0045) 2000; 15
Deuschl (10.1016/j.jocn.2013.02.032_b0080) 2006; 355
Voon (10.1016/j.jocn.2013.02.032_b0105) 2011; 69
Ambermoon (10.1016/j.jocn.2013.02.032_b0010) 2011; 106
Siderowf (10.1016/j.jocn.2013.02.032_b0065) 2002; 17
References_xml – volume: 12
  start-page: 189
  year: 1975
  end-page: 198
  ident: b0075
  article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
– volume: 15
  start-page: S110
  year: 2009
  end-page: S113
  ident: b0005
  article-title: Impulse control disorders in Parkinson’s disease: prevalence and possible risk factors
  publication-title: Parkinsonism Relat Disord
– volume: 52
  start-page: 784
  year: 2004
  end-page: 788
  ident: b0015
  article-title: Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease
  publication-title: J Am Geriatr Soc
– volume: 67
  start-page: 589
  year: 2010
  end-page: 595
  ident: b0025
  article-title: Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients
  publication-title: Arch Neurol
– volume: 17
  start-page: 758
  year: 2002
  end-page: 763
  ident: b0065
  article-title: Test-retest reliability of the unified Parkinson’s disease rating scale in patients with early Parkinson’s disease: results from a multicenter clinical trial
  publication-title: Mov Disord
– volume: 18
  start-page: 467
  year: 2003
  end-page: 486
  ident: b0050
  article-title: Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders
  publication-title: Mov Disord
– volume: 21
  start-page: 1892
  year: 2006
  end-page: 1898
  ident: b0120
  article-title: Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: part II, construct and content validity
  publication-title: Mov Disord
– volume: 24
  start-page: 1461
  year: 2009
  end-page: 1467
  ident: b0090
  article-title: Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease
  publication-title: Mov Disord
– volume: 19
  start-page: 1020
  year: 2004
  end-page: 1028
  ident: b0125
  article-title: Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations
  publication-title: Mov Disord
– volume: 15
  start-page: S111
  year: 2009
  end-page: S115
  ident: b0035
  article-title: Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management
  publication-title: Parkinsonism Relat Disord
– volume: 65
  start-page: 1570
  year: 2005
  end-page: 1574
  ident: b0020
  article-title: Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
  publication-title: Neurology
– volume: 17
  start-page: 60
  year: 2002
  end-page: 67
  ident: b0040
  article-title: Global Parkinson’s Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson’s disease: results from an international survey
  publication-title: Mov Disord
– volume: 106
  start-page: 283
  year: 2011
  end-page: 293
  ident: b0010
  article-title: Impulse control disorders in patients with Parkinson’s disease receiving dopamine replacement therapy: evidence and implications for the addictions field
  publication-title: Addiction
– volume: 16
  start-page: 406
  year: 2010
  end-page: 407
  ident: b0095
  article-title: Detection of impulse control disorders in Parkinson disease patients
  publication-title: Neurologist
– volume: 18
  start-page: 198
  year: 2012
  end-page: 203
  ident: b0110
  article-title: Apathy and impulse control disorders in Parkinson’s disease: a direct comparison
  publication-title: Parkinsonism Relat Disord
– volume: 1
  start-page: 29
  year: 2009
  ident: b0030
  article-title: Impulse control disorders in Parkinson’s disease
  publication-title: F1000 Med Rep
– volume: 15
  start-page: 216
  year: 2000
  end-page: 223
  ident: b0045
  article-title: The quality of life in Parkinson’s disease
  publication-title: Mov Disord
– volume: 18
  start-page: 155
  year: 2012
  end-page: 160
  ident: b0130
  article-title: Impulse control disorders and depression in Finnish patients with Parkinson’s disease
  publication-title: Parkinsonism Relat Disord
– volume: 26
  start-page: 353
  year: 1997
  end-page: 357
  ident: b0085
  article-title: The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score
  publication-title: Age Ageing
– volume: 27
  start-page: 160
  year: 2012
  end-page: 166
  ident: b0135
  article-title: Carer burden in apathy and impulse control disorders in Parkinson’s disease
  publication-title: Int J Geriatr Psychiatry
– volume: 26
  start-page: 464
  year: 2011
  end-page: 468
  ident: b0100
  article-title: Impulsivity and compulsivity in drug-naive patients with Parkinson’s disease
  publication-title: Mov Disord
– volume: 59
  start-page: 22
  year: 1998
  end-page: 33
  ident: b0060
  article-title: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
  publication-title: J Clin Psychiatry
– volume: 18
  start-page: 1
  year: 2012
  end-page: 16
  ident: b0140
  article-title: Nonmotor manifestations in Parkinson disease
  publication-title: Neurologist
– volume: 53
  start-page: 695
  year: 2005
  end-page: 699
  ident: b0070
  article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
  publication-title: J Am Geriatr Soc
– volume: 42
  start-page: 291
  year: 2001
  end-page: 300
  ident: b0055
  article-title: Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview
  publication-title: Compr Psychiatry
– volume: 69
  start-page: 986
  year: 2011
  end-page: 996
  ident: b0105
  article-title: Impulse control disorders in Parkinson disease: a multicenter case–control study
  publication-title: Ann Neurol
– volume: 355
  start-page: 896
  year: 2006
  end-page: 908
  ident: b0080
  article-title: A randomized trial of deep-brain stimulation for Parkinson’s disease
  publication-title: N Engl J Med
– volume: 248
  start-page: 151
  year: 2006
  end-page: 157
  ident: b0115
  article-title: Quality of life and depression in Parkinson’s disease
  publication-title: J Neurol Sci
– volume: 42
  start-page: 291
  year: 2001
  ident: 10.1016/j.jocn.2013.02.032_b0055
  article-title: Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview
  publication-title: Compr Psychiatry
  doi: 10.1053/comp.2001.24586
– volume: 21
  start-page: 1892
  year: 2006
  ident: 10.1016/j.jocn.2013.02.032_b0120
  article-title: Metric attributes of the unified Parkinson’s disease rating scale 3.0 battery: part II, construct and content validity
  publication-title: Mov Disord
  doi: 10.1002/mds.21071
– volume: 18
  start-page: 1
  year: 2012
  ident: 10.1016/j.jocn.2013.02.032_b0140
  article-title: Nonmotor manifestations in Parkinson disease
  publication-title: Neurologist
  doi: 10.1097/NRL.0b013e31823d7abb
– volume: 1
  start-page: 29
  year: 2009
  ident: 10.1016/j.jocn.2013.02.032_b0030
  article-title: Impulse control disorders in Parkinson’s disease
  publication-title: F1000 Med Rep
  doi: 10.3410/M1-29
– volume: 26
  start-page: 464
  year: 2011
  ident: 10.1016/j.jocn.2013.02.032_b0100
  article-title: Impulsivity and compulsivity in drug-naive patients with Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.23501
– volume: 69
  start-page: 986
  year: 2011
  ident: 10.1016/j.jocn.2013.02.032_b0105
  article-title: Impulse control disorders in Parkinson disease: a multicenter case–control study
  publication-title: Ann Neurol
  doi: 10.1002/ana.22356
– volume: 248
  start-page: 151
  year: 2006
  ident: 10.1016/j.jocn.2013.02.032_b0115
  article-title: Quality of life and depression in Parkinson’s disease
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2006.05.030
– volume: 16
  start-page: 406
  year: 2010
  ident: 10.1016/j.jocn.2013.02.032_b0095
  article-title: Detection of impulse control disorders in Parkinson disease patients
  publication-title: Neurologist
  doi: 10.1097/NRL.0b013e3181e8868b
– volume: 15
  start-page: S110
  year: 2009
  ident: 10.1016/j.jocn.2013.02.032_b0005
  article-title: Impulse control disorders in Parkinson’s disease: prevalence and possible risk factors
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(09)70794-1
– volume: 17
  start-page: 758
  year: 2002
  ident: 10.1016/j.jocn.2013.02.032_b0065
  article-title: Test-retest reliability of the unified Parkinson’s disease rating scale in patients with early Parkinson’s disease: results from a multicenter clinical trial
  publication-title: Mov Disord
  doi: 10.1002/mds.10011
– volume: 27
  start-page: 160
  year: 2012
  ident: 10.1016/j.jocn.2013.02.032_b0135
  article-title: Carer burden in apathy and impulse control disorders in Parkinson’s disease
  publication-title: Int J Geriatr Psychiatry
  doi: 10.1002/gps.2704
– volume: 17
  start-page: 60
  year: 2002
  ident: 10.1016/j.jocn.2013.02.032_b0040
  article-title: Global Parkinson’s Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson’s disease: results from an international survey
  publication-title: Mov Disord
  doi: 10.1002/mds.10010
– volume: 53
  start-page: 695
  year: 2005
  ident: 10.1016/j.jocn.2013.02.032_b0070
  article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53221.x
– volume: 19
  start-page: 1020
  year: 2004
  ident: 10.1016/j.jocn.2013.02.032_b0125
  article-title: Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations
  publication-title: Mov Disord
  doi: 10.1002/mds.20213
– volume: 52
  start-page: 784
  year: 2004
  ident: 10.1016/j.jocn.2013.02.032_b0015
  article-title: Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2004.52219.x
– volume: 18
  start-page: 467
  year: 2003
  ident: 10.1016/j.jocn.2013.02.032_b0050
  article-title: Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders
  publication-title: Mov Disord
  doi: 10.1002/mds.10459
– volume: 12
  start-page: 189
  year: 1975
  ident: 10.1016/j.jocn.2013.02.032_b0075
  article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
  doi: 10.1016/0022-3956(75)90026-6
– volume: 355
  start-page: 896
  year: 2006
  ident: 10.1016/j.jocn.2013.02.032_b0080
  article-title: A randomized trial of deep-brain stimulation for Parkinson’s disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa060281
– volume: 18
  start-page: 155
  year: 2012
  ident: 10.1016/j.jocn.2013.02.032_b0130
  article-title: Impulse control disorders and depression in Finnish patients with Parkinson’s disease
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2011.09.007
– volume: 24
  start-page: 1461
  year: 2009
  ident: 10.1016/j.jocn.2013.02.032_b0090
  article-title: Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.22571
– volume: 59
  start-page: 22
  year: 1998
  ident: 10.1016/j.jocn.2013.02.032_b0060
  article-title: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
  publication-title: J Clin Psychiatry
– volume: 106
  start-page: 283
  year: 2011
  ident: 10.1016/j.jocn.2013.02.032_b0010
  article-title: Impulse control disorders in patients with Parkinson’s disease receiving dopamine replacement therapy: evidence and implications for the addictions field
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.03218.x
– volume: 67
  start-page: 589
  year: 2010
  ident: 10.1016/j.jocn.2013.02.032_b0025
  article-title: Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients
  publication-title: Arch Neurol
  doi: 10.1001/archneurol.2010.65
– volume: 26
  start-page: 353
  year: 1997
  ident: 10.1016/j.jocn.2013.02.032_b0085
  article-title: The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score
  publication-title: Age Ageing
  doi: 10.1093/ageing/26.5.353
– volume: 65
  start-page: 1570
  year: 2005
  ident: 10.1016/j.jocn.2013.02.032_b0020
  article-title: Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000184487.72289.f0
– volume: 15
  start-page: S111
  year: 2009
  ident: 10.1016/j.jocn.2013.02.032_b0035
  article-title: Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(09)70847-8
– volume: 15
  start-page: 216
  year: 2000
  ident: 10.1016/j.jocn.2013.02.032_b0045
  article-title: The quality of life in Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#
– volume: 18
  start-page: 198
  year: 2012
  ident: 10.1016/j.jocn.2013.02.032_b0110
  article-title: Apathy and impulse control disorders in Parkinson’s disease: a direct comparison
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2011.10.005
SSID ssj0009430
Score 2.338801
Snippet Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson’s disease (PD). The present study aimed to investigate the...
Abstract Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson’s disease (PD). The present study aimed to...
Impulse control and related disorders (ICRD) are not uncommon in patients with idiopathic Parkinson's disease (PD). The present study aimed to investigate the...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 63
SubjectTerms Activity of daily living
Aged
Disruptive, Impulse Control, and Conduct Disorders - etiology
Female
Humans
Idiopathic Parkinson’s disease
Impulse control and related disorders
Male
Middle Aged
Neurology
Neuropsychological Tests
Parkinson Disease - complications
Parkinson Disease - psychology
Quality of life
Quality of Life - psychology
Severity of Illness Index
Surveys and Questionnaires
Title Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients
URI https://www.clinicalkey.com/#!/content/1-s2.0-S096758681300249X
https://www.clinicalkey.es/playcontent/1-s2.0-S096758681300249X
https://dx.doi.org/10.1016/j.jocn.2013.02.032
https://www.ncbi.nlm.nih.gov/pubmed/24035421
https://www.proquest.com/docview/1469218161
https://www.proquest.com/docview/1516744166
Volume 21
WOSCitedRecordID wos000330149900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1532-2653
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009430
  issn: 0967-5868
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6DiFeEN-Uj8lICB5QUOzmw3mcUCdAW5lEhyJerHzYakuXdEs7jf-AP5u72EkLo2U88BJVkd1Edz9fzne-3xHyUgWuThQPHJbrBNOMzIkERsSEdpN-pMBp1nWziXA4FHEcHXc6P5pamItZWBTi8jKa_1dVwz1QNpbO_oO62z-FG_AblA5XUDtcr6V4y0eMVBCn8-Vs7Th6bpk26wxBbsl1F4aAyRRX1un22UTXTCJYEG1rw8KqyeQ0RKzVBq-2rbRcI8pssXM8Xta2aFVFEdc3vo7V9-Vadv8btmk3lWZfsMyzbB3_o2ScGKYEjF6vhyyYtxaysLFHsM6-MP10GjPM2RW4GZtqDaD5OpsWLVfsvglBTN9OywxJbVm_JmK1kdNfSLaHn-TByeGhHA3i0av5mYP9xzBPb5ux7JBdHvqR6JLd_Q-D-OOKwNmr-9a0r24LsMxZwd8fu8nJ2bSJqZ2Z0R1y2-qL7hv03CUdVdwjN4_sOYv7RBkQ0VJTCyJqQURbENGyoCsQUQARtSDCaQgiOiloC6LXFbUQog2EHpCTg8Ho3XvHNuRwMthHLxwu8ogz-CRx5fkp81Qeap66YZK7Gny9TIt-nimW5jyHTZvQIBEVqNRVYQSrPvH7D0m3KAv1mFCWelohN1EIkhWRFl7KI5a4aZAqjye8R1gjQZlZtnpsmjKTzbHEqUSpS5S6dLkEqffIm3bO3HC1bB3dbxQjm7UB300JkNo6K_zTLFVZC1BJJisYKT8jUhAomC_mXhT3iN_OtKvPeK1_feKLBjUSTD_m85JClcsKd-0ReugB2zLGxzIj2HUFPfLIQK6VDVJx-h5nT64x-ym5tVrJz0h3cb5Uz8mN7GIxqc73yE4Yiz27ZH4CzlzoeA
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+impulse+control+disorders+on+disability+and+quality+of+life+in+Parkinson%27s+disease+patients&rft.jtitle=Journal+of+clinical+neuroscience&rft.au=Phu%2C+Amy&rft.au=Xu%2C+Zheyu&rft.au=Brakoulias%2C+Vlasios&rft.au=Mahant%2C+Neil&rft.date=2014-01-01&rft.issn=0967-5868&rft.volume=21&rft.issue=1&rft.spage=63&rft.epage=66&rft_id=info:doi/10.1016%2Fj.jocn.2013.02.032&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09675868%2FS0967586813X00128%2Fcov150h.gif